Acme India Industries is an SME IPO scheduled to open on 30 Sept 2026 and close on 06 Oct 2026, priced at ₹186 – ₹196 per share, minimum lot 600 shares (~₹2,35,200 for retail). Proposed listing on BSE SME on 09 Oct 2026.
About Acme India Industries
Acme India Industries manufactures and distributes industrial products and equipment. Revenue for FY2026 stood at ₹267.89 crores with a net profit of ₹24.36 crores.
Acme India Industries IPO Details
| IPO Type | SME |
| Price Band | ₹186 – ₹196 per share |
| Lot Size | 600 shares · ~₹2,35,200 for retail |
| Grey Market Premium (GMP) | ₹30 (about 15.3% over the cap price) |
| Listing At | BSE SME |
| Registrar | Bigshare Services Pvt. Ltd. |
Acme India Industries IPO Important Dates
| Event | Date |
|---|---|
| IPO Open Date | 30 Sept 2026 |
| IPO Close Date | 06 Oct 2026 |
| Basis of Allotment | 07 Oct 2026 |
| Refund / UPI Mandate Release | 08 Oct 2026 |
| Credit of Shares to Demat | 08 Oct 2026 |
| Listing Date | 09 Oct 2026 |
Acme India Industries IPO Lot Size & Investment
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail | 2 | 1,200 | ₹2,35,200 |
| HNI | 3 – 8 | 1,800 – 4,800 | ₹3,52,800 – ₹9,40,800 |
Acme India Industries IPO Estimated Listing Price
At the current grey market premium of ₹30, Acme India Industries could list near ₹226 against the upper price of ₹196 — an implied gain of about 15.3%. This is a market estimate only; the real listing price is set by demand on listing day.
Acme India Industries IPO GMP (Grey Market Premium)
The latest grey market premium for Acme India Industries is ₹30 (about 15.3% over the cap price). GMP is an unofficial, over-the-counter figure that can change through the day and is not endorsed by SEBI or the exchanges.
More on Acme India Industries IPO
- Acme India Industries IPO — live GMP, subscription & allotment status
- Acme India Industries IPO listing gain calculator
- All SME IPOs
- Full IPO list with GMP
Allotment and listing-gain details will be published here once available. This article is for information only and is not investment advice. Read the RHP and consider your own risk profile before investing.
Loading comments...